

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA strand elongation (GO:0022616) | 5.82120683 |
| 2 | telomere maintenance via semi-conservative replication (GO:0032201) | 5.42443585 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.41377473 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.41377473 |
| 5 | glycine metabolic process (GO:0006544) | 5.40435864 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.37395320 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.37395320 |
| 8 | serine family amino acid biosynthetic process (GO:0009070) | 4.92088326 |
| 9 | cysteine metabolic process (GO:0006534) | 4.86716591 |
| 10 | nuclear pore complex assembly (GO:0051292) | 4.84601511 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.79780583 |
| 12 | establishment of integrated proviral latency (GO:0075713) | 4.78994843 |
| 13 | mitotic chromosome condensation (GO:0007076) | 4.75882410 |
| 14 | DNA replication checkpoint (GO:0000076) | 4.74492372 |
| 15 | serine family amino acid catabolic process (GO:0009071) | 4.72821222 |
| 16 | serine family amino acid metabolic process (GO:0009069) | 4.67788804 |
| 17 | lysine metabolic process (GO:0006553) | 4.62931748 |
| 18 | lysine catabolic process (GO:0006554) | 4.62931748 |
| 19 | mitotic sister chromatid segregation (GO:0000070) | 4.61147492 |
| 20 | nuclear pore organization (GO:0006999) | 4.60979186 |
| 21 | telomere maintenance via recombination (GO:0000722) | 4.59819528 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.50729249 |
| 23 | kynurenine metabolic process (GO:0070189) | 4.44416108 |
| 24 | * folic acid-containing compound biosynthetic process (GO:0009396) | 4.37338235 |
| 25 | mitotic recombination (GO:0006312) | 4.34573642 |
| 26 | protein localization to kinetochore (GO:0034501) | 4.32740740 |
| 27 | tryptophan catabolic process (GO:0006569) | 4.30147644 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 4.30147644 |
| 29 | indolalkylamine catabolic process (GO:0046218) | 4.30147644 |
| 30 | sister chromatid segregation (GO:0000819) | 4.25034904 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 4.25001678 |
| 32 | protein localization to chromosome, centromeric region (GO:0071459) | 4.23745913 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.20472243 |
| 34 | mitotic metaphase plate congression (GO:0007080) | 4.19683131 |
| 35 | L-serine metabolic process (GO:0006563) | 4.18406532 |
| 36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.15365259 |
| 37 | urea metabolic process (GO:0019627) | 4.12572124 |
| 38 | urea cycle (GO:0000050) | 4.12572124 |
| 39 | tryptophan metabolic process (GO:0006568) | 4.09419735 |
| 40 | bile acid biosynthetic process (GO:0006699) | 4.03634563 |
| 41 | mitotic sister chromatid cohesion (GO:0007064) | 4.03338473 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 3.96465251 |
| 43 | ribosome assembly (GO:0042255) | 3.94721909 |
| 44 | formation of translation preinitiation complex (GO:0001731) | 3.93696645 |
| 45 | alpha-linolenic acid metabolic process (GO:0036109) | 3.87502865 |
| 46 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.86082696 |
| 47 | * tetrahydrofolate metabolic process (GO:0046653) | 3.82930107 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 3.79981740 |
| 49 | mitotic nuclear envelope disassembly (GO:0007077) | 3.77114741 |
| 50 | telomere maintenance via telomere lengthening (GO:0010833) | 3.77109505 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 3.73935415 |
| 52 | regulation of protein activation cascade (GO:2000257) | 3.73010555 |
| 53 | nucleobase biosynthetic process (GO:0046112) | 3.69707020 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.68332225 |
| 55 | IMP metabolic process (GO:0046040) | 3.67770226 |
| 56 | * folic acid metabolic process (GO:0046655) | 3.66840086 |
| 57 | aromatic amino acid family metabolic process (GO:0009072) | 3.62173742 |
| 58 | pore complex assembly (GO:0046931) | 3.60996848 |
| 59 | DNA duplex unwinding (GO:0032508) | 3.59752079 |
| 60 | regulation of fibrinolysis (GO:0051917) | 3.59516934 |
| 61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.59071541 |
| 62 | protein carboxylation (GO:0018214) | 3.58913637 |
| 63 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.58913637 |
| 64 | * one-carbon metabolic process (GO:0006730) | 3.58145637 |
| 65 | establishment of viral latency (GO:0019043) | 3.55481171 |
| 66 | CENP-A containing nucleosome assembly (GO:0034080) | 3.49642026 |
| 67 | chromatin remodeling at centromere (GO:0031055) | 3.49519163 |
| 68 | regulation of complement activation (GO:0030449) | 3.49511422 |
| 69 | metaphase plate congression (GO:0051310) | 3.48754536 |
| 70 | DNA geometric change (GO:0032392) | 3.47648827 |
| 71 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.46689916 |
| 72 | bile acid metabolic process (GO:0008206) | 3.46502569 |
| 73 | negative regulation of sterol transport (GO:0032372) | 3.46478859 |
| 74 | negative regulation of cholesterol transport (GO:0032375) | 3.46478859 |
| 75 | * folic acid-containing compound metabolic process (GO:0006760) | 3.45864470 |
| 76 | nuclear envelope disassembly (GO:0051081) | 3.45147497 |
| 77 | membrane disassembly (GO:0030397) | 3.45147497 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 3.44874620 |
| 79 | non-recombinational repair (GO:0000726) | 3.44729308 |
| 80 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.44729308 |
| 81 | complement activation, alternative pathway (GO:0006957) | 3.42196417 |
| 82 | purine nucleobase biosynthetic process (GO:0009113) | 3.41538489 |
| 83 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.41403854 |
| 84 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.40576821 |
| 85 | heterochromatin organization (GO:0070828) | 3.40387429 |
| 86 | ethanol oxidation (GO:0006069) | 3.39616904 |
| 87 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.39281720 |
| 88 | DNA unwinding involved in DNA replication (GO:0006268) | 3.36021117 |
| 89 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.35583385 |
| 90 | aspartate family amino acid catabolic process (GO:0009068) | 3.32816727 |
| 91 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.30952214 |
| 92 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.30952214 |
| 93 | ribosome biogenesis (GO:0042254) | 3.30888281 |
| 94 | positive regulation of chromosome segregation (GO:0051984) | 3.30385263 |
| 95 | DNA ligation (GO:0006266) | 3.30276507 |
| 96 | DNA topological change (GO:0006265) | 3.30188409 |
| 97 | cellular modified amino acid catabolic process (GO:0042219) | 3.26744444 |
| 98 | glutamate metabolic process (GO:0006536) | 3.25324518 |
| 99 | protein complex localization (GO:0031503) | 3.24968868 |
| 100 | * pteridine-containing compound biosynthetic process (GO:0042559) | 3.24940144 |
| 101 | tyrosine metabolic process (GO:0006570) | 3.20406414 |
| 102 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.18904107 |
| 103 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.18904107 |
| 104 | IMP biosynthetic process (GO:0006188) | 3.17565891 |
| 105 | DNA conformation change (GO:0071103) | 3.17170282 |
| 106 | urate metabolic process (GO:0046415) | 3.16221418 |
| 107 | chromosome condensation (GO:0030261) | 3.15244914 |
| 108 | base-excision repair (GO:0006284) | 3.12983301 |
| 109 | telomere maintenance (GO:0000723) | 3.12019384 |
| 110 | regulation of centriole replication (GO:0046599) | 3.10105369 |
| 111 | telomere organization (GO:0032200) | 3.10050417 |
| 112 | negative regulation of mRNA processing (GO:0050686) | 3.08919399 |
| 113 | maturation of SSU-rRNA (GO:0030490) | 3.08857822 |
| 114 | * imidazole-containing compound metabolic process (GO:0052803) | 3.08657609 |
| 115 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.06941274 |
| 116 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.06904820 |
| 117 | * pteridine-containing compound metabolic process (GO:0042558) | 3.06469108 |
| 118 | regulation of DNA endoreduplication (GO:0032875) | 3.06045528 |
| 119 | triglyceride homeostasis (GO:0070328) | 3.05373092 |
| 120 | acylglycerol homeostasis (GO:0055090) | 3.05373092 |
| 121 | reverse cholesterol transport (GO:0043691) | 3.04936980 |
| 122 | tRNA aminoacylation for protein translation (GO:0006418) | 3.04730861 |
| 123 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04166422 |
| 124 | macromolecular complex remodeling (GO:0034367) | 3.03254934 |
| 125 | plasma lipoprotein particle remodeling (GO:0034369) | 3.03254934 |
| 126 | protein-lipid complex remodeling (GO:0034368) | 3.03254934 |
| 127 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.03158481 |
| 128 | DNA replication-independent nucleosome organization (GO:0034724) | 3.02483313 |
| 129 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.02483313 |
| 130 | regulation of chromosome segregation (GO:0051983) | 3.01876895 |
| 131 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.01704368 |
| 132 | UMP biosynthetic process (GO:0006222) | 3.01704368 |
| 133 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.01704368 |
| 134 | UMP metabolic process (GO:0046049) | 3.01704368 |
| 135 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.01650393 |
| 136 | regulation of cholesterol esterification (GO:0010872) | 3.01047933 |
| 137 | aldehyde catabolic process (GO:0046185) | 3.00916373 |
| 138 | tRNA aminoacylation (GO:0043039) | 3.00492997 |
| 139 | amino acid activation (GO:0043038) | 3.00492997 |
| 140 | regulation of mitochondrial translation (GO:0070129) | 3.00353477 |
| 141 | indolalkylamine metabolic process (GO:0006586) | 2.99335881 |
| 142 | regulation of cholesterol homeostasis (GO:2000188) | 2.99072085 |
| 143 | regulation of sister chromatid cohesion (GO:0007063) | 2.98305866 |
| 144 | bile acid and bile salt transport (GO:0015721) | 2.97790542 |
| 145 | DNA replication initiation (GO:0006270) | 2.97245059 |
| 146 | establishment of chromosome localization (GO:0051303) | 2.96755400 |
| 147 | response to nitrosative stress (GO:0051409) | 2.94835004 |
| 148 | regulation of triglyceride catabolic process (GO:0010896) | 2.94278695 |
| 149 | drug catabolic process (GO:0042737) | 2.94055202 |
| 150 | acetyl-CoA metabolic process (GO:0006084) | 2.93470744 |
| 151 | chromatin assembly or disassembly (GO:0006333) | 2.93343292 |
| 152 | negative regulation of chromosome segregation (GO:0051985) | 2.91755642 |
| 153 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.91732614 |
| 154 | carboxylic acid catabolic process (GO:0046395) | 2.88039214 |
| 155 | organic acid catabolic process (GO:0016054) | 2.88039214 |
| 156 | benzene-containing compound metabolic process (GO:0042537) | 2.87827902 |
| 157 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.87778713 |
| 158 | cellular glucuronidation (GO:0052695) | 2.87501002 |
| 159 | cell cycle G1/S phase transition (GO:0044843) | 2.87117616 |
| 160 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.87117616 |
| 161 | regulation of translational termination (GO:0006449) | 2.87043429 |
| 162 | valine metabolic process (GO:0006573) | 2.86628030 |
| 163 | chromosome segregation (GO:0007059) | 2.86249976 |
| 164 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.85987360 |
| 165 | spindle checkpoint (GO:0031577) | 2.85981040 |
| 166 | blood coagulation, intrinsic pathway (GO:0007597) | 2.84094685 |
| 167 | plasma lipoprotein particle clearance (GO:0034381) | 2.83922203 |
| 168 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.83816595 |
| 169 | * alpha-amino acid biosynthetic process (GO:1901607) | 2.83602433 |
| 170 | ribosomal small subunit biogenesis (GO:0042274) | 2.83122102 |
| 171 | regulation of translational fidelity (GO:0006450) | 2.82571933 |
| 172 | negative regulation of RNA splicing (GO:0033119) | 2.82321436 |
| 173 | proline biosynthetic process (GO:0006561) | 2.82257822 |
| 174 | drug metabolic process (GO:0017144) | 2.82154671 |
| 175 | negative regulation of mRNA metabolic process (GO:1903312) | 2.82038923 |
| 176 | regulation of centrosome cycle (GO:0046605) | 2.81932170 |
| 177 | cellular biogenic amine catabolic process (GO:0042402) | 2.80748075 |
| 178 | amine catabolic process (GO:0009310) | 2.80748075 |
| 179 | histone exchange (GO:0043486) | 2.80670553 |
| 180 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.80654340 |
| 181 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.79876858 |
| 182 | DNA replication (GO:0006260) | 2.79141178 |
| 183 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.78662418 |
| 184 | kinetochore organization (GO:0051383) | 2.78578104 |
| 185 | DNA packaging (GO:0006323) | 2.78002717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.77560260 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.71681048 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.77386948 |
| 4 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.56398027 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.51470419 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.47186055 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.09370113 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.90503460 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.76276624 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64943723 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.56126630 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.52373018 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.41752378 |
| 14 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37878496 |
| 15 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.32887994 |
| 16 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.28608086 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.17596455 |
| 18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.08721060 |
| 19 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.99457867 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.97107826 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94696869 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94670018 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.93947119 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.89320762 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.88653970 |
| 26 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.82413961 |
| 27 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.81907001 |
| 28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.80203609 |
| 29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78753716 |
| 30 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.75517195 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.67030044 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59878673 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58217764 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.58205338 |
| 35 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54997481 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54119604 |
| 37 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.52847514 |
| 38 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.49633132 |
| 39 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46225595 |
| 40 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.46104453 |
| 41 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.45315044 |
| 42 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.44841152 |
| 43 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.44246252 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44130598 |
| 45 | MYC_22102868_ChIP-Seq_BL_Human | 1.43292008 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43222990 |
| 47 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.39795789 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.39474111 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.38369577 |
| 50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.38250522 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.35506629 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33546117 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33183925 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31074736 |
| 55 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.28953590 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26539911 |
| 57 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.25431327 |
| 58 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.24590259 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24502358 |
| 60 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.22536009 |
| 61 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.21523040 |
| 62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17227827 |
| 63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14424809 |
| 64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.14249986 |
| 65 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13681927 |
| 66 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13549206 |
| 67 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.12394520 |
| 68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.11395734 |
| 69 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10284350 |
| 70 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07993582 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07899485 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.06479731 |
| 73 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05093970 |
| 74 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04388994 |
| 75 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04084665 |
| 76 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03566685 |
| 77 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02479309 |
| 78 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.01006858 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00084706 |
| 80 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99932933 |
| 81 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.99338316 |
| 82 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98314933 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97388013 |
| 84 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.97248473 |
| 85 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96409255 |
| 86 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96279734 |
| 87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95864842 |
| 88 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.95405491 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95027958 |
| 90 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94525972 |
| 91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93459607 |
| 92 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92703837 |
| 93 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.91938553 |
| 94 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91919296 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91609898 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89488906 |
| 97 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88685994 |
| 98 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.88240574 |
| 99 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88128255 |
| 100 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.87774892 |
| 101 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86392753 |
| 102 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.86087619 |
| 103 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.86008819 |
| 104 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.86008819 |
| 105 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.86008819 |
| 106 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.85373150 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85372396 |
| 108 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.85266001 |
| 109 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.85125754 |
| 110 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.84838566 |
| 111 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.84233834 |
| 112 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84225688 |
| 113 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.84209822 |
| 114 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.83567489 |
| 115 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.81023787 |
| 116 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79619862 |
| 117 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.78410415 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77342802 |
| 119 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76024816 |
| 120 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.73500153 |
| 121 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73167467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.58077416 |
| 2 | MP0005360_urolithiasis | 6.09622867 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.05404800 |
| 4 | MP0005365_abnormal_bile_salt | 4.74351092 |
| 5 | * MP0003806_abnormal_nucleotide_metabolis | 4.25240956 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.70036865 |
| 7 | MP0003252_abnormal_bile_duct | 2.98643650 |
| 8 | MP0009840_abnormal_foam_cell | 2.87168116 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.60838758 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.53190884 |
| 11 | MP0005083_abnormal_biliary_tract | 2.49701741 |
| 12 | * MP0005332_abnormal_amino_acid | 2.34966703 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.34346823 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.10497105 |
| 15 | MP0003111_abnormal_nucleus_morphology | 2.10173362 |
| 16 | MP0003195_calcinosis | 2.04549806 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.03311380 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.94922601 |
| 19 | MP0000609_abnormal_liver_physiology | 1.88499935 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.80143941 |
| 21 | MP0003186_abnormal_redox_activity | 1.79282352 |
| 22 | MP0003941_abnormal_skin_development | 1.74576941 |
| 23 | MP0004233_abnormal_muscle_weight | 1.73412688 |
| 24 | MP0003077_abnormal_cell_cycle | 1.72080510 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.67000483 |
| 26 | MP0008057_abnormal_DNA_replication | 1.65157197 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.60091927 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.59301858 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.58699236 |
| 30 | MP0001764_abnormal_homeostasis | 1.58545060 |
| 31 | * MP0005319_abnormal_enzyme/_coenzyme | 1.56587011 |
| 32 | MP0001730_embryonic_growth_arrest | 1.47598410 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.43854594 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.40236834 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.38901859 |
| 36 | MP0000598_abnormal_liver_morphology | 1.33304597 |
| 37 | MP0003868_abnormal_feces_composition | 1.31509745 |
| 38 | MP0001346_abnormal_lacrimal_gland | 1.28322974 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.24817748 |
| 40 | MP0003718_maternal_effect | 1.24810490 |
| 41 | MP0008058_abnormal_DNA_repair | 1.18870905 |
| 42 | MP0005501_abnormal_skin_physiology | 1.15626287 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07163566 |
| 44 | MP0009053_abnormal_anal_canal | 1.06651800 |
| 45 | MP0003315_abnormal_perineum_morphology | 1.05935569 |
| 46 | MP0004264_abnormal_extraembryonic_tissu | 1.04225446 |
| 47 | MP0000350_abnormal_cell_proliferation | 1.03256270 |
| 48 | MP0001672_abnormal_embryogenesis/_devel | 1.02230605 |
| 49 | MP0005380_embryogenesis_phenotype | 1.02230605 |
| 50 | MP0002697_abnormal_eye_size | 1.02143763 |
| 51 | MP0010307_abnormal_tumor_latency | 1.01715280 |
| 52 | MP0000537_abnormal_urethra_morphology | 1.00770956 |
| 53 | MP0005220_abnormal_exocrine_pancreas | 0.98800999 |
| 54 | MP0001881_abnormal_mammary_gland | 0.98651335 |
| 55 | MP0009697_abnormal_copulation | 0.98401082 |
| 56 | MP0002796_impaired_skin_barrier | 0.97813626 |
| 57 | MP0009672_abnormal_birth_weight | 0.97143736 |
| 58 | MP0008932_abnormal_embryonic_tissue | 0.95576754 |
| 59 | MP0002086_abnormal_extraembryonic_tissu | 0.94443743 |
| 60 | MP0008007_abnormal_cellular_replicative | 0.93957718 |
| 61 | MP0003937_abnormal_limbs/digits/tail_de | 0.93817259 |
| 62 | * MP0002080_prenatal_lethality | 0.92894843 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 0.92703505 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.91746931 |
| 65 | MP0001697_abnormal_embryo_size | 0.91720220 |
| 66 | MP0003984_embryonic_growth_retardation | 0.91535034 |
| 67 | MP0010030_abnormal_orbit_morphology | 0.91344763 |
| 68 | MP0002088_abnormal_embryonic_growth/wei | 0.91202745 |
| 69 | * MP0005266_abnormal_metabolism | 0.90247157 |
| 70 | MP0004197_abnormal_fetal_growth/weight/ | 0.88818270 |
| 71 | MP0003890_abnormal_embryonic-extraembry | 0.82504756 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 0.82023985 |
| 73 | MP0009763_increased_sensitivity_to | 0.81821342 |
| 74 | MP0005384_cellular_phenotype | 0.79533844 |
| 75 | MP0002210_abnormal_sex_determination | 0.79401477 |
| 76 | MP0001661_extended_life_span | 0.79230336 |
| 77 | MP0002163_abnormal_gland_morphology | 0.79059808 |
| 78 | MP0002009_preneoplasia | 0.76699922 |
| 79 | MP0005621_abnormal_cell_physiology | 0.76562376 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 0.75196263 |
| 81 | MP0002160_abnormal_reproductive_system | 0.74587835 |
| 82 | MP0000627_abnormal_mammary_gland | 0.74290445 |
| 83 | MP0006054_spinal_hemorrhage | 0.73741986 |
| 84 | MP0002084_abnormal_developmental_patter | 0.73521373 |
| 85 | MP0002111_abnormal_tail_morphology | 0.73387183 |
| 86 | MP0009703_decreased_birth_body | 0.73091935 |
| 87 | MP0005647_abnormal_sex_gland | 0.72649310 |
| 88 | * MP0005376_homeostasis/metabolism_phenot | 0.71957745 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.71525826 |
| 90 | MP0003123_paternal_imprinting | 0.71502330 |
| 91 | MP0005670_abnormal_white_adipose | 0.70638916 |
| 92 | MP0000579_abnormal_nail_morphology | 0.70219334 |
| 93 | MP0000358_abnormal_cell_content/ | 0.70208320 |
| 94 | MP0002396_abnormal_hematopoietic_system | 0.70013025 |
| 95 | MP0002085_abnormal_embryonic_tissue | 0.70000892 |
| 96 | MP0005408_hypopigmentation | 0.69831943 |
| 97 | MP0001727_abnormal_embryo_implantation | 0.69735754 |
| 98 | MP0005330_cardiomyopathy | 0.69546083 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.69248814 |
| 100 | MP0005023_abnormal_wound_healing | 0.68976848 |
| 101 | MP0001915_intracranial_hemorrhage | 0.68405157 |
| 102 | MP0001145_abnormal_male_reproductive | 0.68039960 |
| 103 | MP0005395_other_phenotype | 0.67079201 |
| 104 | MP0002970_abnormal_white_adipose | 0.66731891 |
| 105 | MP0001756_abnormal_urination | 0.66126377 |
| 106 | MP0002234_abnormal_pharynx_morphology | 0.66005702 |
| 107 | MP0006292_abnormal_olfactory_placode | 0.65878805 |
| 108 | MP0005451_abnormal_body_composition | 0.65748847 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.65671290 |
| 110 | MP0002938_white_spotting | 0.65388936 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.64741940 |
| 112 | MP0001849_ear_inflammation | 0.64396233 |
| 113 | MP0003119_abnormal_digestive_system | 0.63694908 |
| 114 | MP0001929_abnormal_gametogenesis | 0.63660517 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.63376999 |
| 116 | MP0002060_abnormal_skin_morphology | 0.62662509 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.61552604 |
| 118 | MP0004043_abnormal_pH_regulation | 0.61389124 |
| 119 | MP0001286_abnormal_eye_development | 0.61247486 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.61186254 |
| 121 | MP0004133_heterotaxia | 0.60094712 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.60073675 |
| 123 | MP0003786_premature_aging | 0.59746827 |
| 124 | MP0002269_muscular_atrophy | 0.59096170 |
| 125 | MP0003011_delayed_dark_adaptation | 0.59091057 |
| 126 | MP0002078_abnormal_glucose_homeostasis | 0.58540106 |
| 127 | MP0008877_abnormal_DNA_methylation | 0.58221099 |
| 128 | MP0000490_abnormal_crypts_of | 0.57777816 |
| 129 | MP0008469_abnormal_protein_level | 0.57384107 |
| 130 | MP0000313_abnormal_cell_death | 0.57303136 |
| 131 | MP0002136_abnormal_kidney_physiology | 0.56734975 |
| 132 | MP0000653_abnormal_sex_gland | 0.56575968 |
| 133 | MP0008873_increased_physiological_sensi | 0.55981150 |
| 134 | MP0001293_anophthalmia | 0.55194726 |
| 135 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54076886 |
| 136 | MP0003283_abnormal_digestive_organ | 0.51355001 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.50924613 |
| 138 | MP0000477_abnormal_intestine_morphology | 0.49251898 |
| 139 | MP0003566_abnormal_cell_adhesion | 0.49165144 |
| 140 | MP0002877_abnormal_melanocyte_morpholog | 0.49102540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.20751076 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.20508376 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 6.05450492 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.83312886 |
| 5 | Chromsome breakage (HP:0040012) | 5.73267908 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.58292842 |
| 7 | Deep venous thrombosis (HP:0002625) | 5.32468862 |
| 8 | Xanthomatosis (HP:0000991) | 4.74794932 |
| 9 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.69333135 |
| 10 | Hyperglycinemia (HP:0002154) | 4.39526911 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.34608372 |
| 12 | Hyperammonemia (HP:0001987) | 4.28337028 |
| 13 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.20886315 |
| 14 | Hyperglycinuria (HP:0003108) | 4.09166102 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 3.95980447 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.95749658 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.94926664 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 3.94926664 |
| 19 | Hypoglycemic coma (HP:0001325) | 3.94702700 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.79462684 |
| 21 | Ketosis (HP:0001946) | 3.66703978 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.58028987 |
| 23 | Abnormality of glycolysis (HP:0004366) | 3.55385238 |
| 24 | Abnormality of the preputium (HP:0100587) | 3.55096740 |
| 25 | Spastic diplegia (HP:0001264) | 3.54549164 |
| 26 | Meckel diverticulum (HP:0002245) | 3.48078203 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.41689823 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.37954479 |
| 29 | Complement deficiency (HP:0004431) | 3.37549423 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.32201642 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 3.28572130 |
| 32 | Abnormality of the ileum (HP:0001549) | 3.27793358 |
| 33 | Abnormality of chromosome stability (HP:0003220) | 3.26129518 |
| 34 | Microvesicular hepatic steatosis (HP:0001414) | 3.24419934 |
| 35 | Increased serum pyruvate (HP:0003542) | 3.22224206 |
| 36 | Epidermoid cyst (HP:0200040) | 3.21937009 |
| 37 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.20893285 |
| 38 | Fat malabsorption (HP:0002630) | 3.20293264 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.16796943 |
| 40 | Increased nuchal translucency (HP:0010880) | 3.11387269 |
| 41 | Hypoalphalipoproteinemia (HP:0003233) | 3.09922203 |
| 42 | Hyperbilirubinemia (HP:0002904) | 3.07225679 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.05742963 |
| 44 | Progressive muscle weakness (HP:0003323) | 2.98233536 |
| 45 | Gout (HP:0001997) | 2.95642921 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.94191548 |
| 47 | Joint hemorrhage (HP:0005261) | 2.93501199 |
| 48 | Ketoacidosis (HP:0001993) | 2.79393815 |
| 49 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.79067837 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.72947620 |
| 51 | Abnormality of the carotid arteries (HP:0005344) | 2.67954215 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.63350064 |
| 53 | Abnormality of complement system (HP:0005339) | 2.62059597 |
| 54 | Small intestinal stenosis (HP:0012848) | 2.61043777 |
| 55 | Duodenal stenosis (HP:0100867) | 2.61043777 |
| 56 | Oral leukoplakia (HP:0002745) | 2.59968959 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.58191627 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54001537 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.54001537 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.50693964 |
| 61 | Lethargy (HP:0001254) | 2.50609115 |
| 62 | Selective tooth agenesis (HP:0001592) | 2.50078878 |
| 63 | Ependymoma (HP:0002888) | 2.43284476 |
| 64 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41228853 |
| 65 | Trismus (HP:0000211) | 2.41025691 |
| 66 | Megaloblastic anemia (HP:0001889) | 2.39992397 |
| 67 | Reduced antithrombin III activity (HP:0001976) | 2.39415517 |
| 68 | Proximal placement of thumb (HP:0009623) | 2.38874961 |
| 69 | Hypercholesterolemia (HP:0003124) | 2.38082246 |
| 70 | Myelodysplasia (HP:0002863) | 2.37618914 |
| 71 | Metabolic acidosis (HP:0001942) | 2.36011562 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.35498873 |
| 73 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.33565741 |
| 74 | Steatorrhea (HP:0002570) | 2.32443288 |
| 75 | Late onset (HP:0003584) | 2.32348989 |
| 76 | Acanthocytosis (HP:0001927) | 2.31923751 |
| 77 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.31801147 |
| 78 | Deviation of the thumb (HP:0009603) | 2.29453101 |
| 79 | Reticulocytosis (HP:0001923) | 2.29164988 |
| 80 | Abnormal cartilage morphology (HP:0002763) | 2.26349724 |
| 81 | Absent radius (HP:0003974) | 2.25909574 |
| 82 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.22148135 |
| 83 | Malnutrition (HP:0004395) | 2.19601234 |
| 84 | Abnormality of the duodenum (HP:0002246) | 2.18257061 |
| 85 | Squamous cell carcinoma (HP:0002860) | 2.18253229 |
| 86 | Irritability (HP:0000737) | 2.18045721 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.16963531 |
| 88 | Poikilocytosis (HP:0004447) | 2.14832061 |
| 89 | Hyperacusis (HP:0010780) | 2.14507089 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 2.14198984 |
| 91 | Embryonal renal neoplasm (HP:0011794) | 2.13702013 |
| 92 | Horseshoe kidney (HP:0000085) | 2.12065936 |
| 93 | Ectopic kidney (HP:0000086) | 2.10943422 |
| 94 | Multiple enchondromatosis (HP:0005701) | 2.10709378 |
| 95 | Ragged-red muscle fibers (HP:0003200) | 2.10581292 |
| 96 | Cerebral edema (HP:0002181) | 2.10208231 |
| 97 | Aplasia involving forearm bones (HP:0009822) | 2.10047799 |
| 98 | Absent forearm bone (HP:0003953) | 2.10047799 |
| 99 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.08404653 |
| 100 | Choanal atresia (HP:0000453) | 2.08078635 |
| 101 | Rhabdomyosarcoma (HP:0002859) | 2.07885642 |
| 102 | Cafe-au-lait spot (HP:0000957) | 2.06975081 |
| 103 | Birth length less than 3rd percentile (HP:0003561) | 2.06485194 |
| 104 | High pitched voice (HP:0001620) | 2.05915071 |
| 105 | Abnormality of reticulocytes (HP:0004312) | 2.05816145 |
| 106 | Absent thumb (HP:0009777) | 2.04718925 |
| 107 | Neonatal onset (HP:0003623) | 2.03844056 |
| 108 | Colon cancer (HP:0003003) | 2.02766110 |
| 109 | Abnormality of the umbilical cord (HP:0010881) | 2.02736477 |
| 110 | Pancytopenia (HP:0001876) | 2.01291121 |
| 111 | Progressive external ophthalmoplegia (HP:0000590) | 2.00164046 |
| 112 | Skin nodule (HP:0200036) | 1.99935294 |
| 113 | Pseudobulbar signs (HP:0002200) | 1.98819119 |
| 114 | Abnormality of cochlea (HP:0000375) | 1.98465822 |
| 115 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.97115999 |
| 116 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.96086741 |
| 117 | Volvulus (HP:0002580) | 1.94426211 |
| 118 | Increased purine levels (HP:0004368) | 1.93397650 |
| 119 | Hyperuricemia (HP:0002149) | 1.93397650 |
| 120 | Cholelithiasis (HP:0001081) | 1.93340009 |
| 121 | Esophageal varix (HP:0002040) | 1.93326300 |
| 122 | Abnormal gallbladder morphology (HP:0012437) | 1.92255319 |
| 123 | Cortical dysplasia (HP:0002539) | 1.91037410 |
| 124 | Insomnia (HP:0100785) | 1.90194616 |
| 125 | Abnormal lung lobation (HP:0002101) | 1.89831739 |
| 126 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89617400 |
| 127 | Septate vagina (HP:0001153) | 1.89050313 |
| 128 | Atresia of the external auditory canal (HP:0000413) | 1.88908989 |
| 129 | Increased serum ferritin (HP:0003281) | 1.88355593 |
| 130 | Sloping forehead (HP:0000340) | 1.88284186 |
| 131 | Triphalangeal thumb (HP:0001199) | 1.88245551 |
| 132 | Increased serum lactate (HP:0002151) | 1.87524724 |
| 133 | Clubbing of toes (HP:0100760) | 1.87368778 |
| 134 | Overlapping toe (HP:0001845) | 1.85651419 |
| 135 | Nausea (HP:0002018) | 1.85191605 |
| 136 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.84942235 |
| 137 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.84942235 |
| 138 | Microglossia (HP:0000171) | 1.83469497 |
| 139 | Abnormal number of erythroid precursors (HP:0012131) | 1.81342996 |
| 140 | Overriding aorta (HP:0002623) | 1.81120756 |
| 141 | Macrocytic anemia (HP:0001972) | 1.80953777 |
| 142 | Abnormality of the labia minora (HP:0012880) | 1.80803554 |
| 143 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78934065 |
| 144 | Patellar aplasia (HP:0006443) | 1.78823663 |
| 145 | Brushfield spots (HP:0001088) | 1.77988820 |
| 146 | Back pain (HP:0003418) | 1.77004139 |
| 147 | Vomiting (HP:0002013) | 1.76500630 |
| 148 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.76436947 |
| 149 | Abnormality of alanine metabolism (HP:0010916) | 1.76436947 |
| 150 | Hyperalaninemia (HP:0003348) | 1.76436947 |
| 151 | Opisthotonus (HP:0002179) | 1.76068456 |
| 152 | Type I transferrin isoform profile (HP:0003642) | 1.75967292 |
| 153 | Poikiloderma (HP:0001029) | 1.75685560 |
| 154 | Short thumb (HP:0009778) | 1.75607461 |
| 155 | Glioma (HP:0009733) | 1.74210667 |
| 156 | Facial cleft (HP:0002006) | 1.72963751 |
| 157 | Proximal tubulopathy (HP:0000114) | 1.72866355 |
| 158 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.71416218 |
| 159 | Impulsivity (HP:0100710) | 1.71290172 |
| 160 | Arteriovenous malformation (HP:0100026) | 1.70100809 |
| 161 | Abnormality of the astrocytes (HP:0100707) | 1.69981552 |
| 162 | Astrocytoma (HP:0009592) | 1.69981552 |
| 163 | Medulloblastoma (HP:0002885) | 1.68982675 |
| 164 | Myocardial infarction (HP:0001658) | 1.68426132 |
| 165 | Vascular calcification (HP:0004934) | 1.66621958 |
| 166 | Abnormal gallbladder physiology (HP:0012438) | 1.65165310 |
| 167 | Cholecystitis (HP:0001082) | 1.65165310 |
| 168 | Breast hypoplasia (HP:0003187) | 1.65132264 |
| 169 | Hyperglycemia (HP:0003074) | 1.64804530 |
| 170 | Reticulocytopenia (HP:0001896) | 1.64307091 |
| 171 | Spontaneous abortion (HP:0005268) | 1.62776449 |
| 172 | Rhabdomyolysis (HP:0003201) | 1.62468642 |
| 173 | Limb hypertonia (HP:0002509) | 1.62309927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.06147727 |
| 2 | WEE1 | 3.39174463 |
| 3 | CDC7 | 3.22024477 |
| 4 | VRK2 | 3.21565813 |
| 5 | BUB1 | 3.11147334 |
| 6 | NEK1 | 2.93806457 |
| 7 | SMG1 | 2.83052525 |
| 8 | PBK | 2.58420547 |
| 9 | EIF2AK1 | 2.45008826 |
| 10 | PKN2 | 2.43757489 |
| 11 | EPHA2 | 2.32254378 |
| 12 | FLT3 | 2.32041717 |
| 13 | TTK | 2.22154157 |
| 14 | PASK | 2.20336015 |
| 15 | EEF2K | 2.16293861 |
| 16 | NEK2 | 2.14992917 |
| 17 | TSSK6 | 2.06290341 |
| 18 | TAF1 | 1.99635628 |
| 19 | SCYL2 | 1.92659337 |
| 20 | CDK12 | 1.89659659 |
| 21 | RPS6KB2 | 1.86027007 |
| 22 | ZAK | 1.81921976 |
| 23 | MAP3K10 | 1.73505867 |
| 24 | TRIB3 | 1.66316425 |
| 25 | CDK8 | 1.62833397 |
| 26 | FGFR4 | 1.62355254 |
| 27 | SIK1 | 1.59434741 |
| 28 | CDK4 | 1.58549823 |
| 29 | TESK2 | 1.57653944 |
| 30 | ACVR1B | 1.57366087 |
| 31 | ERN1 | 1.55757803 |
| 32 | NME2 | 1.55094771 |
| 33 | MAP3K8 | 1.53842598 |
| 34 | PLK1 | 1.44246698 |
| 35 | CDK7 | 1.42438574 |
| 36 | BRSK2 | 1.39129149 |
| 37 | MST1R | 1.33829142 |
| 38 | STK10 | 1.31665103 |
| 39 | AURKB | 1.29563355 |
| 40 | EIF2AK3 | 1.25434405 |
| 41 | ERBB4 | 1.23814496 |
| 42 | ATR | 1.22670663 |
| 43 | KDR | 1.17717589 |
| 44 | NME1 | 1.15419292 |
| 45 | AURKA | 1.13679417 |
| 46 | SRPK1 | 1.11220360 |
| 47 | TGFBR1 | 1.08012111 |
| 48 | MKNK2 | 1.06632190 |
| 49 | MAPK11 | 1.06365430 |
| 50 | MAP2K3 | 1.06217866 |
| 51 | DYRK3 | 1.05682706 |
| 52 | EIF2AK2 | 1.05219372 |
| 53 | TLK1 | 1.04955548 |
| 54 | CDK6 | 1.04777668 |
| 55 | IRAK3 | 1.04069928 |
| 56 | RPS6KA4 | 1.00522007 |
| 57 | PAK4 | 1.00289435 |
| 58 | CHEK1 | 0.98551129 |
| 59 | LRRK2 | 0.96511669 |
| 60 | MTOR | 0.94307385 |
| 61 | MAP3K11 | 0.90762040 |
| 62 | CHEK2 | 0.89515900 |
| 63 | PTK6 | 0.88871757 |
| 64 | STK38L | 0.88828594 |
| 65 | VRK1 | 0.84586403 |
| 66 | MET | 0.84308454 |
| 67 | MAPKAPK3 | 0.84144530 |
| 68 | GRK6 | 0.84114291 |
| 69 | MAP3K3 | 0.82418543 |
| 70 | MST4 | 0.82182429 |
| 71 | PNCK | 0.81402020 |
| 72 | STK4 | 0.80877681 |
| 73 | LATS1 | 0.80831125 |
| 74 | CCNB1 | 0.79217859 |
| 75 | PLK4 | 0.77884048 |
| 76 | PLK3 | 0.76795867 |
| 77 | STK16 | 0.76447930 |
| 78 | PIM1 | 0.75780617 |
| 79 | DAPK1 | 0.75502705 |
| 80 | ALK | 0.75162271 |
| 81 | CDK2 | 0.72328461 |
| 82 | CSNK2A2 | 0.71676851 |
| 83 | ATM | 0.68331009 |
| 84 | CDK9 | 0.67758277 |
| 85 | PDK4 | 0.67629826 |
| 86 | PDK3 | 0.67629826 |
| 87 | TAOK3 | 0.65938345 |
| 88 | BRSK1 | 0.65670586 |
| 89 | NUAK1 | 0.64976583 |
| 90 | CLK1 | 0.61741574 |
| 91 | TAOK2 | 0.58069669 |
| 92 | CSNK1E | 0.57338645 |
| 93 | BRD4 | 0.57162032 |
| 94 | AKT2 | 0.54421225 |
| 95 | PRKCI | 0.54111379 |
| 96 | ABL2 | 0.53809075 |
| 97 | MAPKAPK5 | 0.52759738 |
| 98 | CSNK2A1 | 0.52495680 |
| 99 | TYK2 | 0.49016215 |
| 100 | MAP3K9 | 0.44174326 |
| 101 | CDK1 | 0.43483639 |
| 102 | BRAF | 0.42177651 |
| 103 | JAK2 | 0.41621610 |
| 104 | FGFR1 | 0.41080205 |
| 105 | MAP4K1 | 0.40779952 |
| 106 | PAK2 | 0.40520663 |
| 107 | INSRR | 0.39495156 |
| 108 | PDK2 | 0.39280881 |
| 109 | CDK15 | 0.39114250 |
| 110 | MAP2K2 | 0.38875040 |
| 111 | CDK11A | 0.38456832 |
| 112 | STK3 | 0.38169284 |
| 113 | CDK18 | 0.37668028 |
| 114 | WNK3 | 0.36963565 |
| 115 | TTN | 0.36391595 |
| 116 | MELK | 0.36204181 |
| 117 | LATS2 | 0.35606329 |
| 118 | CSNK1D | 0.34662877 |
| 119 | NEK9 | 0.33354016 |
| 120 | ERBB2 | 0.32304605 |
| 121 | PRKDC | 0.31238112 |
| 122 | MAPK14 | 0.31025733 |
| 123 | CDK14 | 0.30241175 |
| 124 | MAP3K5 | 0.29783544 |
| 125 | MKNK1 | 0.29490071 |
| 126 | PAK1 | 0.29062324 |
| 127 | GSK3A | 0.28870893 |
| 128 | ICK | 0.28825625 |
| 129 | ILK | 0.24793569 |
| 130 | TRIM28 | 0.23837393 |
| 131 | PTK2 | 0.22192148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.26179364 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.95285001 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92608756 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90602292 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64797729 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.59223165 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.45820491 |
| 8 | * One carbon pool by folate_Homo sapiens_hsa00670 | 2.32107726 |
| 9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.31209566 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.19844118 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07539549 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.07059801 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06381522 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 2.04268570 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.02699252 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.91079249 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.87177298 |
| 18 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.85644554 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.80560670 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77098560 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76130403 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.73560619 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.71905972 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.69059593 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67122315 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62692898 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.59607884 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59448591 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.58000692 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.54660162 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.50389996 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42239442 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40041289 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.39477966 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39471742 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38516705 |
| 37 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.37419311 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.36191181 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.33576851 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31885865 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24622335 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22067787 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20819626 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20112298 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19522361 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18741616 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.17349985 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16194572 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13444566 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11387687 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 1.10269399 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09169189 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05887200 |
| 54 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.04159820 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99616253 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.99124966 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97342894 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96803896 |
| 59 | Spliceosome_Homo sapiens_hsa03040 | 0.96116040 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94499185 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94187171 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.94113188 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.94102330 |
| 64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.93107798 |
| 65 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90929215 |
| 66 | Proteasome_Homo sapiens_hsa03050 | 0.85566097 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83754483 |
| 68 | Ribosome_Homo sapiens_hsa03010 | 0.83409077 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80771534 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.78124249 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75814294 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.75283642 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.72680629 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70504004 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66299132 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65035384 |
| 77 | Cell cycle_Homo sapiens_hsa04110 | 0.64766236 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64742919 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60711577 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60474843 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60252557 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57917082 |
| 83 | Protein export_Homo sapiens_hsa03060 | 0.55463018 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54714667 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53414622 |
| 86 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.53047933 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52752235 |
| 88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49918673 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49459489 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46990255 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44102437 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43369197 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41515117 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39535781 |
| 95 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39244157 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.37328687 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33092824 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32722641 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32174283 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32106257 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30073742 |
| 102 | Purine metabolism_Homo sapiens_hsa00230 | 0.29146922 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27800144 |
| 104 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.22469960 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18153088 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.16576239 |
| 107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.14093175 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.13527632 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.13438891 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12738914 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.11715491 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.11293184 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.10328207 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.10029050 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09923435 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07071867 |

